中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
99-100
,共2页
奥曲肽%泮托拉唑%治疗%胃十二指肠溃疡出血%疗效
奧麯肽%泮託拉唑%治療%胃十二指腸潰瘍齣血%療效
오곡태%반탁랍서%치료%위십이지장궤양출혈%료효
Octreotide%Pantozol%Treatment%Bleeding gastroduodenal ulcer%The curative effect
目的：研究分析奥曲肽联合泮托拉唑治疗胃十二指肠溃疡出血的临床疗效。方法回顾性分析该院于2012年12月-2014年2月收治的100例胃十二指肠溃疡出血患者的病历资料，随机的分为对照组和治疗组，对照组和治疗组各50例，对照组患者采取泮托拉唑治疗，治疗组患者采取奥曲肽联合泮托拉唑治疗，对比分析两组患者的止血效果、临床疗效和不良反应情况。结果治疗组患者治疗1 d后止血效果明显优于对照组，P<0.05，治疗2 d后的止血效果和对照组患者止血效果比较，P>0.05，差异无统计学意义。治疗组患者的临床总有效率明显大于对照组，P<0.05，治疗组患者不良反应发生率小于对照组，P<0.05。结论胃十二指肠溃疡出血患者实施奥曲肽联合泮托拉唑治疗，有较好的止血效果和较少的不良反应，临床疗效显著，有一定的安全性和可行性，值得临床推广应用。
目的：研究分析奧麯肽聯閤泮託拉唑治療胃十二指腸潰瘍齣血的臨床療效。方法迴顧性分析該院于2012年12月-2014年2月收治的100例胃十二指腸潰瘍齣血患者的病歷資料，隨機的分為對照組和治療組，對照組和治療組各50例，對照組患者採取泮託拉唑治療，治療組患者採取奧麯肽聯閤泮託拉唑治療，對比分析兩組患者的止血效果、臨床療效和不良反應情況。結果治療組患者治療1 d後止血效果明顯優于對照組，P<0.05，治療2 d後的止血效果和對照組患者止血效果比較，P>0.05，差異無統計學意義。治療組患者的臨床總有效率明顯大于對照組，P<0.05，治療組患者不良反應髮生率小于對照組，P<0.05。結論胃十二指腸潰瘍齣血患者實施奧麯肽聯閤泮託拉唑治療，有較好的止血效果和較少的不良反應，臨床療效顯著，有一定的安全性和可行性，值得臨床推廣應用。
목적：연구분석오곡태연합반탁랍서치료위십이지장궤양출혈적림상료효。방법회고성분석해원우2012년12월-2014년2월수치적100례위십이지장궤양출혈환자적병력자료，수궤적분위대조조화치료조，대조조화치료조각50례，대조조환자채취반탁랍서치료，치료조환자채취오곡태연합반탁랍서치료，대비분석량조환자적지혈효과、림상료효화불량반응정황。결과치료조환자치료1 d후지혈효과명현우우대조조，P<0.05，치료2 d후적지혈효과화대조조환자지혈효과비교，P>0.05，차이무통계학의의。치료조환자적림상총유효솔명현대우대조조，P<0.05，치료조환자불량반응발생솔소우대조조，P<0.05。결론위십이지장궤양출혈환자실시오곡태연합반탁랍서치료，유교호적지혈효과화교소적불량반응，림상료효현저，유일정적안전성화가행성，치득림상추엄응용。
Objective To study the clinical curative effect of octreotide combined with pantozol in treatment of bleeding gastroduo-denal ulcer. Methods Medical records of 100 cases of gastric duodenal ulcer hemorrhage patients admitted to our hospital from December 2012 to February 2014 were retrospectively analyzed and randomly divided into control group and treatment group, 50 cases in control group patients taking panxi tora azole treatment, the treatment group patients taking the octreotide combined with panxi tora azole treatment. Hemostatic effect of two groups of patients, clinical efficacy and adverse reactions were compared. Re-sults The treatment group patients after treatment of 1 d hemostatic effect was obvious due to the control group,P<0.05, 2 d after treatment, the hemostatic effect of hemostatic effect, and the control group patients (P>0.05, no significant difference. The clinical total effective rate of treatment group patients was significantly greater than the control group, P< 0.05. The treatment group pa-tients incidence of adverse reaction was less than the control group,P<0.05). Conclusion Octreotide combined with diazepam tora azole treatment for patients with gastroduodenal ulcer bleeding, has good hemostatic effect, fewer adverse reactions, distinct effect , certain feasibility and security, so it is worthy of clinical popularization and application.
